Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Cash from Investing Activities (2017 - 2024)

Historic Cash from Investing Activities for Q32 Bio (QTTB) over the last 8 years, with Q4 2024 value amounting to -$2000.0.

  • Q32 Bio's Cash from Investing Activities changed N/A to -$2000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$2000.0, marking a year-over-year decrease of 10001.0%. This contributed to the annual value of $19.9 million for FY2024, which is 39860000.0% up from last year.
  • As of Q4 2024, Q32 Bio's Cash from Investing Activities stood at -$2000.0.
  • Q32 Bio's Cash from Investing Activities' 5-year high stood at $168.3 million during Q1 2022, with a 5-year trough of -$108.2 million in Q3 2022.
  • In the last 5 years, Q32 Bio's Cash from Investing Activities had a median value of $97000.0 in 2024 and averaged $11.1 million.
  • As far as peak fluctuations go, Q32 Bio's Cash from Investing Activities crashed by 249208.66% in 2022, and later skyrocketed by 99430000.0% in 2024.
  • Quarter analysis of 5 years shows Q32 Bio's Cash from Investing Activities stood at -$955000.0 in 2020, then soared by 4671.83% to $43.7 million in 2021, then crashed by 58.79% to $18.0 million in 2022, then tumbled by 100.01% to -$1000.0 in 2023, then crashed by 100.0% to -$2000.0 in 2024.
  • Its last three reported values are -$2000.0 in Q4 2024, $9.9 million for Q3 2024, and $9.9 million during Q2 2024.